J&J's Profit Beats Analysts' Estimates on Prostate Cancer, Psoriasis Drugs - Bloomberg

Bakersfield Now J&J's Profit Beats Analysts' Estimates on Prostate Cancer, disease of the skin Drugs Bloomberg Photographer: prophet Acker/Bloomberg Johnson & Samuel Johnson (JNJ), the world's second-biggest maker of health-care products, said profit beat analysts' estimates, boosted by type A weakening dollar and brand-new drugs for prostate malignant tumor and psoriasis . ... J&J 2Q profit drops 20 percent, still beatniks views The Associated estate Johnson & Johnson beatniks Estimates, Profit Falls connected Domestic Recalls Forbes (blog) Johnson & Johnson Reports 2011 Second-Quarter Results: MarketWatch (press release) Reuters  - Toronto Star  - PMLiVE all 303 news articles » Link To Article